Our analyst predicts, the Global Bacteriophage Therapy market is expected to reach USD 1 Billion till 2027 growing at a CAGR of 6.1%. The report provides in-depth forecast and analysis on the Bacteriophage therapy Market on a global and regional level. The research study provides historical data from 2016 to 2019 along with forecast data from 2020 to 2027. This research study on Bacteriophage Therapy market includes drivers and restraints along with the impact they have on the demand over the forecast period. Also this research study provides the opportunities available in Bacteriophage Therapy Market on global level.
The Global Bacteriophage Market report is segmented by Application, By Type, By End-User, By Region.
By Type the bacteriophage Market report is further bifurcated into Lytic, Lysogenic. By Application the report is further bifurcated into Vetinary Medicine, Antimicrobial Drug Discovery, Diagonstic etc. By end-user, the report is further bifurcated into Hospital, Academic Research Organizations & Institutes.
Based on geography, the Bacteriophage Market report is divided into North America, Europe, Asia-Pacific, South America and Middle East and Africa. North America is further divided into the US, Canada, Mexico whereas Europe consists of the UK, Germany, France, Italy and Rest of Europe. Asia-Pacific is segmented into Japan, South Korea, India, China and Rest of Asia-Pacific. The South America region includes Brazil, Argentina and the Rest of South America, while the Middle East and Africa is categorized into GCC Countries, Egypt, South Africa and Rest of Middle East and Africa.
Key Players Operating in Global bacteriophage Market are Pherecydes Pharma, OCUS BIOSCIENCES, INC., Fixed-Phage Limited, Phage International, Inc., iNtODEWORLD, Inc., Armata Pharmaceuticals, Inc., Adaptive Phage Therapeutics, Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC.
Global Bacteriophage Market Report Segmentation
- Vetinary Medicine
- Antimicrobial Drug Discovery
- Academic Research Organizations & Institutes
- North America(US, Canada, Mexico)
- Europe(UK, Germany, France, Italy and Rest of Europe)
- Asia-Pacific(Japan, South Korea, India, China and Rest of Asia-Pacific)
- South America(Brazil, Argentina and the Rest of South America)
- Middle East and Africa(GCC Countries, Egypt, South Africa and Rest of Middle East and Africa)
By Key Players
- Pherecydes Pharma
- OCUS BIOSCIENCES, INC.
- Fixed-Phage Limited
- Phage International, Inc.
- iNtODEWORLD, Inc.
- Armata Pharmaceuticals, Inc.
- Adaptive Phage Therapeutics
- Intralytix, Inc
- PhagoMed Biopharma GmbH
- PHAGELUX, INC
Key Questions answered in this report:
- Full In Depth Analysis of Bacteriophage Therapy Market?
- What was the market size from 2016 to 2019?
- What will be the market growth till 2027?
- What are the market drivers, restraints and opportunities and their impact on the market?
- Detailed segmentation of the market?
- What are the key strategies of Major players?